Working… Menu

Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00286169
Recruitment Status : Terminated
First Posted : February 3, 2006
Last Update Posted : August 10, 2010
Information provided by:
Sumitomo Dainippon Pharma Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Study Completion Date : No date given